Cystatin C as a more sensitive indicator of diminished glomerular filtration rate

Liver Transplantation

Volumn 11, Issue 3, 2005, Pages 264-266

  Heilman, Raymond L ^a,b,c   Mazur, Mark J ^a,b,c  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC HOSPITAL   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYSTATIN C; IMMUNOSUPPRESSIVE AGENT; INULIN;

CHRONIC DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INULIN CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; CYSTATINS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; SENSITIVITY AND SPECIFICITY;

EID: 16244381450     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20361     Document Type: Editorial

References (13)

1. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001; 72:1934-1939.
2. Skluzacek PA, Szewc RG, Nolan CR, 3rd, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003;42:1169-1176.
3. Henriksen JH, Brochner-Mortensen J, Malchow-Moller A, Schlichting P. Over-estimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites. Scand J Clin Lab Invest 1980;40:279-284.
4. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C - a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101:875-881.
5. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47:2055-2059.
6. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan JC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-1421.
7. Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002;50:106-110.
8. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002;48(Pt 1):850-858.
9. Bokenkamp A, Ozden N, Dieterich C, Schumann G, Ehrich JH, Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clin Nephrol 1999;52:371-376.
10. Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, et al. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C. levels. Liver Transpl 2002;8:594-599.
11. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002;48:699-707.
12. Leung N. A tale of two markers. Liver Transpl 2002;8:600-602.
13. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005;11:344-349.